Skip to main content
Fig. 5 | European Journal of Medical Research

Fig. 5

From: Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice

Fig. 5

Treatment with BIBF1000 reduced the secretion of airway mucus and lung fibrosis. A Representative Periodic acid Schiff (PAS) staining for mucus and Masson’s trichrome staining for collagen deposition in airways. Quantitative analysis of: B mucus secretion and C lung fibrosis. All values are the mean ± SEM. N = 8. #p < 0.05 vs. the sham control group, *p < 0.05 vs. the vehicle group

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us